series-c-plus
Stage
2
Investors
About
Biosplice Therapeutics is a clinical-stage biotechnology company developing therapeutics based on alternative splicing modulation.
Explore Biosplice Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.